Dr. Edison Tak-Bun LIU Executive Director, Singapore Cancer Syndicate and Genome Institute of Singapore
CV
| 1969-1973 | Stanford University, B.S. Chemistry, Psychology |
| 1973-1978 | Stanford University, M.D |
| 1985-1987 | Instructor, Department of Medicine, Division of Oncology (University of California at San Francisco) |
| 1987-1993 | Assistant Professor in Medicine and Oncology, School of Medicine University of North Carolina at Chapel Hill |
| 1988-1993 | Director Preleukemic Clinic, North Carolina Memorial Hospital |
| 1993-1996 | Leader, Breast Cancer Program, Lineberger Comprehensive Cancer Center |
| 1996-2001 | Director, Division of Clinical Sciences, National Cancer Institute, Bethesda, MD |
| 1997-2001 | Chief, Molecular Signaling and Oncogenesis Section, Department of Cell and Cancer Biology, Medicine Branch, |
| Division of Clinical Sciences, National Cancer Institute | |
| 2001 | -present Executive Director, Genome Institute of Singapore |
| -present Professor of Medicine, National University of Singapore, Special Advisor to the Vice Chancellor | |
| -present Professor, Department of Community, Occupational and Family Medicine (COFM), National University of Singapore | |
| 2002 | -present Executive Director, Singapore Tissue Network |
| 2003 | -present Executive Director, Singapore Cancer Syndicate (funding-agency) |
| 2005 | -present Adjunct Professor of Molecular and Cellular Biology at the University of Champaign-Urbana. |
Mitgliedschaften
| American Federation for Clinical Research | |
| American Association for the Advancement of Science | |
| American Society of Hematology | |
| American Society for Clinical Investigation (elected) | |
| Cancer and Leukemia Group B: Chair, Solid Tumor Correlative Sciences-Committee, resigned 1996 | |
| American Association for Cancer Research, Clinical Cancer Research Committee, resigned 2000 | |
| American Association for Cancer Research, Board of Directors, elected 2000-2002 | |
| American Association for Cancer Research, AACR International Affairs Committee, 2002-2005 | |
| International Genetics Federation, Board of Advisors, 2003 |
Publikationen
| An Introduction to the Concept of Cancer Genes, Springer-Verlag, 1988 | |
| The Role of ras Gene Mutations in Myeloproliferative Disorders, in: Myeloproliferative Disorders. Clinics in Laboratory Medicine, W.B. Saunders Co, 1989 | |
| Breast Cancer Research: Where we are and where we should go, Breast Cancer Research, 2000 | |
| Defining the Galaxy of Gene Expression in Breast Cancer, Breast Cancer Research, 2002 | |
| Oncogenes and Suppressor Genes: Genetic Control of Cancer, in: Cecil Textbook of Medicine (22st Edition), W.B. Saunders, 2003 | |
| Expression genomics and drug development: towards predictive pharmacology. Brief Funct Genomic Proteomic, 2005 |
Auszeichnungen
| Clinical Investigator Award, National Cancer Institute, 1985-1988 | |
| Brinker International Award for Breast Cancer Research, 1996 | |
| Rosenthal Award, AACR: for the discovery that HER-2 status determines response to adjuvant chemotherapy with doxorubicin, 2000 | |
| Public Service Medal (National Day, 2003): for work in controlling SARS in Singapore (given by the Office of the President, Republic of Singapore), 2003 |
